Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
The Bev-IP trial is designed to assess the feasibility and efficacy of a combined treatment consisting of perioperative combination chemotherapy with the vascular endothelial growth factor A inhibitor bevacizumab and cytoreductive surgery with intraperitoneal oxaliplatin.
创建时间：
2015-12-15
